Categories : Endocrine & Metabolic
Product Packaging : 10 / 30 tablets
Product Composition : 0.2 mg + 500 mg, 0.3 mg + 500 mg
Send MessageVoglibose + Metformin HCL SR Tablets are an effective dual-action oral antidiabetic formulation designed to control both post-meal and baseline blood glucose levels in patients with type 2 diabetes mellitus. Voglibose works by inhibiting intestinal alpha-glucosidase enzymes, thereby slowing carbohydrate digestion and reducing postprandial glucose spikes, while Metformin SR provides sustained reduction in hepatic glucose production and improves insulin sensitivity.
This combination offers a balanced and extended glycemic control approach, especially beneficial for patients with fluctuating glucose levels after meals. The sustained-release technology ensures prolonged drug action and better gastrointestinal tolerance for long-term therapy.
Genliva Wellness LLP, India, is a trusted voglibose metformin SR tablets manufacturer India, delivering high-quality formulations for domestic markets and international pharmaceutical exports.
Voglibose + Metformin HCl SR Tablets are combination antidiabetic formulations specially designed to control post-meal glucose absorption and improve insulin sensitivity in type 2 diabetes mellitus. The sustained-release Metformin provides prolonged glucose regulation, while Voglibose delays carbohydrate digestion and absorption in the intestine.
These tablets are prescribed for patients with type 2 diabetes who experience elevated post-meal blood sugar levels and require combination therapy for better metabolic control.
Voglibose + Metformin HCl SR Tablets provide targeted control of meal-related glucose fluctuations with sustained metabolic support for improved diabetic management.
